1.
Marcellusi A, Bini C, Muzii B, Soudani S, Kieffer A, Beuvelet M, Bozzola E, Midulla F, Baraldi E, Bonanni P, Boccalini S, Orfeo L. Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in Italy. Grhta [Internet]. 2025 Jan. 29 [cited 2025 Feb. 5];12(1):16-28. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/3182